SCHEMBL8358162

SCHEMBL8358162

Cc1cccnc1C(=O)c1ccccn1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.55
▸ LMNA P02545 1/20 0.55
▸ NAPRT Q6XQN6 1/20 0.55
▸ P4HTM Q9NXG6 1/20 0.55
▸ KMT2A Q03164 2/20 0.55
▸ ALDH1A1 P00352 2/20 0.53
▸ CES2 O00748 1/20 0.52
▸ CES1 P23141 1/20 0.52
▸ CTNNB1 P35222 1/20 0.51
▸ WNT3A P56704 1/20 0.51
▸ RAB9A P51151 2/20 0.50
▸ NPC1 O15118 1/20 0.50
▸ KDM4E B2RXH2 1/20 0.46
▸ GSK3B P49841 1/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ HSD17B14 Q9BPX1 1/20 0.43
▸ PDE10A Q9Y233 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2240328 0.85 L3MBTL1 (0.47) L3MBTL1LMNANAPRTP4HTMKMT2A
SCHEMBL15988749 0.80 CTNNB1 (0.70) L3MBTL1LMNANAPRTP4HTMKMT2A
SCHEMBL13161971 0.80 CTNNB1 (0.66) L3MBTL1LMNANAPRTP4HTMKMT2A
SCHEMBL17263069 0.80 KMT2A (0.52) L3MBTL1LMNANAPRTP4HTMKMT2A
SCHEMBL29639199 0.78 NPC1 (0.51) L3MBTL1LMNANAPRTP4HTMKMT2A
SCHEMBL22406333 0.78 RAB9A (0.57) KMT2AALDH1A1CES2CES1RAB9A
SCHEMBL31369148 0.78 KMT2A (0.75) L3MBTL1LMNANAPRTP4HTMKMT2A
SCHEMBL87791 0.78 KMT2A (0.75) L3MBTL1LMNANAPRTP4HTMKMT2A
SCHEMBL8994495 0.77 ALDH1A1 (0.65) L3MBTL1LMNANAPRTP4HTMKMT2A
Charcoal, Activated SCHEMBL8358164 0.76 KMT2A (0.72) L3MBTL1LMNANAPRTP4HTMKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7572927-B2 Method of producing an o-disubstituted aromatic compound, and method of producing a monosubstituted-monohaloaromatic compound FUJIFILM CORPORATION (JP) 2009-08-11 — — US disclosed
US-20080194816-A1 Method of producing an o-disubstituted aromatic compound, and method of producing a monosubstituted-monohaloaromatic compound FUJIFILM CORPORATION (JP) 2008-08-14 — — US disclosed
US-5942527-A Hydrazones, hydrazines, semicarbazones and thiosemicarbazones derived from pyridyl ketones as anticonvulsant drugs and excitatory amino acid antagonists K & K BIOSCIENCES, INC. (US) 1999-08-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194816-A1 Method of producing an o-disubstituted aromatic compound, and method of producing a monosubstituted-monohaloaromatic compound DDT, OXER1, OSTC L3MBTL1 808/4885LMNA 1595/4885NAPRT 3016/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback